Indiana University-Purdue University Indianapolis (IUPUI) / About 50 million years ago, an Hsmar1 transposon invaded an early primate genome and inserted itself downstream of a SET methyltransferase gene, leading to the birth of a new chimeric protein now called SETMAR. While all other Hsmar1 sequences in the human genome have suffered inactivating mutational damage, the transposase domain of SETMAR has remained remarkably intact, suggesting that it has gained a novel, evolutionarily advantageous function. While SETMAR can no longer transpose itself throughout the genome, it has retained its ancestral sequence-specific DNA binding activity, the importance of which is currently unknown. To investigate this, we performed ChIP-seq to examine SETMAR binding in the human genome. We also utilized RNA-sequencing to assess SETMAR overexpression as well as SETMAR deletion on the human transcriptome. Additionally, we explored SETMAR’s transposase-derived chromatin-looping ability using chromosome-conformation-capture-on-ChIP (4C) in the presence of SETMAR overexpression and performed genome-wide Hi-C to assess the impact of complete SETMAR silencing on global chromatin interactions. ChIP-seq revealed that SETMAR amassed 7,332 unique binding sites, 69% of which included a TIR motif. RNA-sequencing in cells overexpressing SETMAR indicated 177 differentially regulated transcripts, including repression of 17 histone transcripts, suggesting a possible role in chromatin dynamics. RNA-sequencing of parental and SETMAR knockout clones highlighted an average of 5,000 altered transcripts in each cell line, with 343 transcripts significantly differentially expressed in all three knockout clones, many of which participate in embryonic development pathways. 4C analysis in the presence of SETMAR overexpression discovered multiple intrachromosomal looping interactions, and Hi-C analysis of SETMAR knockout cell lines uncovered genome-wide loss of chromatin interactions and disruption of TAD boundaries. The prevalence of SETMAR binding in the human genome combined with its chromatin looping capability and its dramatic effects on the transcriptome suggest a previously undiscovered role for SETMAR as a novel chromatin organizing factor. / 2022-08-17

SETMAR est un gène chimérique constitué d’un domaine SET (codant des fonctions d’histone méthylase) et du domaine MAR (ayant conservé certaines fonctions de la transposase HsMAR1). Des études ont montré que les deux domaines sont biologiquement actifs et sont impliqués dans la stabilité et/ou dans la régulation de l’expression du génome humain. La littérature suggère que l’expression de SETMAR est plus forte dans les cellules cancéreuses que dans les cellules saines. Notre hypothèse de travail est que la protéine SETMAR est surexprimée en conditions pathologiques, permettant aux cellules de franchir les points de contrôle du cycle cellulaire, contribuant ainsi à augmenter l’instabilité génétique. Notre objectif est d’étudier la régulation de l’expression de SETMAR et son implication dans l’oncogenèse, gliale en particulier. / SETMAR is a chimeric gene consisting of a SET domain (encoding methylase histone functions) and a MAR domain (having retained some of the of the HsMAR1 transposase functions). Studies have shown that the two domains are biologically active and are involved in the stability and / or in the regulation of the human genome expression. The literature suggests that SETMAR expression is higher in cancer cells than in normal cells. Our working hypothesis is that SETMAR protein is overexpressed in pathological conditions, allowing cells to overcome the cellular cycle checkpoints, helping to increase the genetic instability. Our goal is to study the regulation of the SETMAR expression and its involvement in oncogenesis, glial in particular.

Indiana University-Purdue University Indianapolis (IUPUI) / The nuclear protein SETMAR has been reported to be involved in many processes such as non-homologous end joining (NHEJ), di-methylation (arguably) of K36 of histone H3, restart of stalled replication forks, chromosome decatenation, enhancing of TOPII inhibitors which results in resistance to chemotherapeutics in cancer patients, etc. All these purported functions are impossible to execute without interaction with other proteins. It is established that SETMAR binds specifically to DNA at terminal inverted repeat sequences and can loop DNA. This DNA sequence specific pull-down exploits this attribute to identify possible protein interactors of SETMAR. As a result of this experiment several proteins have been identified for further research: BAG2, c12orf45, PPIA, XRCC5/6, and ZBTB43, all of which are found in higher statistical abundances in full length SETMAR samples.

Le phénomène dit de domestication moléculaire qui a été rapporté pour certains transposons à ADN a abouti à la formation de néogènes qui codent des protéines potentiellement impliquées dans la stabilité du génome de part une activité recombinase. L’objectif de ce travail est d’étudier l’expression de 23 recombinases néogéniques d’intérêt dérivées de transpsons à ADN dans une série de cancers colorectaux. Nous avons fabriqué de nouveaux anticorps performants pour l’étude en western blot et en immunofluorescence de l’expression du gène SETMAR qui code pour la protéine Metnase dans des lignées cancéreuse différentes et dans des tissus du côlon tumoraux et normaux. Nos résultats démontrent que la vaccination d’ADN avec la formulation utilisée est une méthode qui donne de meilleurs résultats que l'injection de peptide ou protéines purifiées. Nous avons observé une expression de la protéine metnase dans des lignées cancéreuses de cancer du côlon, de leucémie et de cancer du sein. Le niveau d’expression de cette protéine Metnase dans le cancer du côlon semble être associé au statut MSI ce qui suggère un rôle de cette protéine dans les mécanismes de carcinogenèse et de progression tumorale. / During a phenomena known as molecular domestication has been reported for some DNA transposons leading to the formation of Neogenes which encode proteins potentially involved in the genome stability. The objective of this work is to study the expression of 23 neogenic recombinases of interest derived from DNA transpsons in a series of frozen colorectal cancers. We have manufactured new effective antibodies for the study of the expression of SETMAR gene which encode Metnase protein in different cancer cell lines and tissues of colon tumoral and normal by the method of Western blot and immunofluorescence. Our results demonstrate that DNA vaccination with the formulation used here is a method that gives better results than the injection of peptide or purified proteins. We observed an expression of Metnase protein in cell lines of colorectal cancer, leukemia and breast cancer. The level of expression of the Metnase protein in colon cancer appears to be associated to the MSI status which suggests a role for this protein in the mechanisms of carcinogenesis and tumor progression.

Indiana University-Purdue University Indianapolis (IUPUI) / SETMAR is a chimeric protein that originates from the fusion of a SET domain to the mariner Hsmar1 transposase. This fusion event occurred approximately 50 million years ago, after the split of an anthropoid primate ancestor from the prosimians. Thus, SETMAR is only expressed in anthropoid primates, such as humans, apes, and New World monkeys. Evolutionary sequence analyses have revealed that the DNA-binding domain, one of the two functional domains in the Hsmar1 transposase, has been subjected to a strong purifying selection. Consistent with these analyses, SETMAR retains robust binding specificity to its ancestral terminal inverted repeat (TIR) DNA. In the human genome, this TIR sequence is dispersed in over 1500 perfect or nearly perfect sites. Given that many DNA-binding domains of transcriptional regulators are derived from transposases, we hypothesized that SETMAR may play a role in gene regulation. In this thesis, we determined the crystal structures of the DNA-binding domain bound to both its ancestral TIR DNA and a variant TIR DNA sequence at 2.37 and 3.07 Å, respectively. Overall, the DNA-binding domain contains two helix-turn-helix (HTH) motifs linked by two AT-hook motifs and dimerizes through its HTH1 motif. In both complexes, minor groove interactions with the AT-hook motifs are similar, and major groove interactions with HTH1 involve a single residue. However, four residues from HTH2 participate in nucleobase-specific interactions with the TIR and only two with the variant DNA sequence. Despite these differences in nucleobase-specific interactions, the DNA-binding affinities of SETMAR to TIR or variant TIR differ by less than two-fold. From cell-based studies, we found that SETMAR represses firefly luciferase gene expression while the DNA-binding deficient mutant does not. A chromatin immunoprecipitation assay further confirms that SETMAR binds the TIR sequence in cells. Collectively, our studies suggest that SETMAR functions in gene regulation.